Document is current
Any future updates will be listed below
-
Authors
Joki, Nobuhiko
Toida, Tatsunori
Niihata, Kakuya
Inanaga, Ryohei
Nakata, Kenji
Abe, Masanori
Hanafusa, Norio
Kurita, Noriaki
- License Information
-
More Information
Article History
Received: 13 January 2025
Revised: 10 April 2025
Accepted: 18 April 2025
First Online: 19 May 2025
Compliance with ethical standards
:
: TT received consulting fees from Astellas Pharma Inc., as well as payments and educational events from Torii Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., AstraZeneca K.K., and Nobelpharma Co., Ltd. RI received payment for speaking from Astellas Pharma, Inc., Novartis Pharma K.K., and Otsuka Pharmaceutical. MA received payment for speaking from Novartis Pharma K.K. and Otsuka Pharmaceutical. NK received consulting fees from GlaxoSmithKline K.K. and payments for speaking and educational events from Eisai Co., Ltd., Taisho Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., GlaxoSmithKline K.K., Takeda Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., and Baxter Corporation.
: The requirement for written informed consent was waived owing to the retrospective nature of this study.
